CDKN2BAS is the most differentially expressed lncRNA, whose expression was 10 times higher than that in the non-metastatic group, implying that CDKN2BAS may be involved in the progression and metastasis of HCC. Here, CDKN2B-AS1 is linked to hepatocellular carcinoma.